Barclays
CLCD

Barclays’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Barclays’s Portfolio CLCD Stock Details CLCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,530
Closed -$310K – 7201
2016
Q4 		$310K Buy
+8,530
New +$302K ﹤0.01% 3811

Other funds holding CLCD

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Barclays's CLCD Position: Q1 2017 in Review

Barclays sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 8,530 shares — an estimated $310K sold.

Barclays first reported a position in CLCD in Q4 2016 and held it in 1 quarter. The position peaked at $310K in Q4 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

  • Barclays reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Barclays sold 8,530 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $310K.
  • Barclays first reported a position in CoLucid Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Barclays's CoLucid Pharmaceuticals, Inc. position peaked at $310K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.